bupranolol and mdl 100907

bupranolol has been researched along with mdl 100907 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baranowska, M; Kozłowska, H; Kozłowski, M; Malinowska, B; Schlicker, E	1

Other Studies

1 other study(ies) available for bupranolol and mdl 100907

Article	Year
Potential involvement of a propranolol-insensitive atypical beta-adrenoceptor the vasodilator effect of cyanopindolol in the human pulmonary artery. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2006, Volume: 57, Issue:3 Topics: Adrenergic beta-Antagonists; Analysis of Variance; Bupranolol; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; In Vitro Techniques; Male; Middle Aged; Pindolol; Pulmonary Artery; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Serotonin 5-HT2 Receptor Antagonists; Vasoconstriction; Vasodilation; Vasodilator Agents	2006

Article

Year

Potential involvement of a propranolol-insensitive atypical beta-adrenoceptor the vasodilator effect of cyanopindolol in the human pulmonary artery.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2006, Volume: 57, Issue:3

Topics: Adrenergic beta-Antagonists; Analysis of Variance; Bupranolol; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; In Vitro Techniques; Male; Middle Aged; Pindolol; Pulmonary Artery; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Serotonin 5-HT2 Receptor Antagonists; Vasoconstriction; Vasodilation; Vasodilator Agents

2006